These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

100 related articles for article (PubMed ID: 4441418)

  • 21. Effects of some benzodiazepine derivatives on Triton WR-1339-Induced hyperlipidaemia in rats.
    Horák J; Cuparencu B; Cucuianu M; Opincaru A; Seusan E; Vincze I
    Atherosclerosis; 1976; 24(1-2):81-97. PubMed ID: 8063
    [TBL] [Abstract][Full Text] [Related]  

  • 22. The pathogenesis of hyperlipemia induced by means of surface-active agents. II. Failure of exchange of cholesterol between the plasma and the liver in rabbits given triton WR 1339.
    HIRSCH RL; KELLNER A
    J Exp Med; 1956 Jul; 104(1):15-24. PubMed ID: 13332177
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Normolipemic activities of acrylophenone derivatives with antimicrotubular properties.
    Bard JM; Luyckx M; Brunet C; Cazin M; Fruchart JC; Clavey V; Lesieur I; Lesieur D; Delacourte A
    Methods Find Exp Clin Pharmacol; 1985 Apr; 7(4):183-7. PubMed ID: 4021650
    [TBL] [Abstract][Full Text] [Related]  

  • 24. The failure of nicotine to affect plasma free fatty acids and triglyceride secretion in anaesthetized rabbits given Triton WR-1339.
    Topping DL; Turner DM
    Biochem Med; 1976 Aug; 16(1):16-20. PubMed ID: 1008866
    [No Abstract]   [Full Text] [Related]  

  • 25. [A comparison of the effects of pyridine- and piperidine-carboxylic acids on the fatty acid content of the serum of rats treated with Triton WR-1339].
    Freyss-Beguin M; van Brussel E; Lechat P
    Therapie; 1970; 25(5):857-62. PubMed ID: 5486149
    [No Abstract]   [Full Text] [Related]  

  • 26. A procedure for inducing sustained hyperlipemia in rats by administration of a surfactant.
    Levine S; Saltzman A
    J Pharmacol Toxicol Methods; 2007; 55(2):224-6. PubMed ID: 16839786
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Weak resistance to oxidation of native lipoproteins in Wistar rats.
    Antébi H; Zimmermann L; Malagrida L; Pecquery R; Olichon D; Giudicelli Y; Alcindor LG
    Ann Nutr Metab; 1993; 37(2):62-7. PubMed ID: 8517635
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [Serum and liver findings following megadoses of Vitamin A].
    Bayerle H; Meister P; Wolff H
    Arzneimittelforschung; 1973 Aug; 23(8):1082-5. PubMed ID: 4801032
    [No Abstract]   [Full Text] [Related]  

  • 29. [The role of changes in matrix metalloproteases and chitotriosidase in the mechanism of protective effect of atorvastatin in experimental murine lipemia].
    Korolenko TA; Cherkanova MS; Savchenko NG; Klishevich MS
    Eksp Klin Farmakol; 2009; 72(4):25-7. PubMed ID: 19803366
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [Studies on primary hyperlipoproteinemia. 3. Disturbances of carbohydrate metabolism].
    Ciświcka-Sznajderman M
    Pol Arch Med Wewn; 1971 May; 46(5):577-83. PubMed ID: 5566930
    [No Abstract]   [Full Text] [Related]  

  • 31. [Comparative effect of pyridine carboxylic and piperidine carboxylic acids on hypercholesteremia and hyperlipoproteinemia induced in rats by injection of Triton WR-1339].
    Freyss-Beguin M; Lechat P
    Therapie; 1968; 23(6):1343-55. PubMed ID: 5713555
    [No Abstract]   [Full Text] [Related]  

  • 32. Hyperlipidemia and pulmonary fat embolism in dogs with E. coli bacteremia.
    Groves AC; Duff JH; McLean AP; MacLean LD
    Surgery; 1970 Oct; 68(4):656-61. PubMed ID: 4919609
    [No Abstract]   [Full Text] [Related]  

  • 33. [Effect of arginine on the lipid and lipoprotein content of animal blood].
    Ryzhenkov VE; Shanygina KI; Chistiakova AM; Miroshkina VN; Parfenova NS
    Vopr Med Khim; 1984; 30(6):76-9. PubMed ID: 6528539
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Moderate ethanol ingestion and plasma triglyceride levels. A study in normal and hypertriglyceridemic persons.
    Ginsberg H; Olefsky J; Farquhar JW; Reaven GM
    Ann Intern Med; 1974 Feb; 80(2):143-9. PubMed ID: 4359737
    [No Abstract]   [Full Text] [Related]  

  • 35. The pathogenesis of hyperlipemia induced by means of surface-active agents. I. Increased total body cholesterol in mice given triton WR 1339 parenterally.
    HIRSCH RL; KELLNER A
    J Exp Med; 1956 Jul; 104(1):1-13. PubMed ID: 13332176
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [In vitro peroxidation of plasma and erythrocyte lipids during WR-1339 induced hyperlipidemia in Wistar rats].
    Zimmermann L; Antébi H; Morvan-Bourcier C; Alcindor LG
    Ann Pharm Fr; 1997; 55(6):246-53. PubMed ID: 9453169
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Triton-induced hyperlipidemia: a model for studies of intestinal lipoprotein production.
    Holt PR; Dominguez AA
    Am J Physiol; 1980 May; 238(5):G453-7. PubMed ID: 7377356
    [TBL] [Abstract][Full Text] [Related]  

  • 38. THE COMPOSITION OF THE PLASMA LIPOPROTEINS IN EXPERIMENTAL HYPERLIPAEMIA INDUCED BY TRITON WR-1339, CORTISONE, ALLOXAN AND HAEMORRHAGE IN RABBITS.
    COURTICE FC; MUNOZ-MARCUS M
    Q J Exp Physiol Cogn Med Sci; 1964 Oct; 49():430-40. PubMed ID: 14223303
    [No Abstract]   [Full Text] [Related]  

  • 39. Triton hyperlipemia in dogs. I. In vitro effects of the detergent on serum lipoproteins and chylomcrons.
    SCANU A; ORIENTE P
    J Exp Med; 1961 Apr; 113(4):735-57. PubMed ID: 13747054
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Hypolipemic activity of plafibride.
    Bruseghini L; Vilageliu J; Bagaria A
    Arzneimittelforschung; 1981; 31(10a):1796-800. PubMed ID: 7198456
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.